cytarabine and Cardiac Arrest, Sudden

cytarabine has been researched along with Cardiac Arrest, Sudden in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Distel, L; Grabenbauer, G; Holter, W; Neubauer, S; Varon, R	1
Aird, W; Amrein, P; MacNeill, K; Neuberg, D; Shulman, LN; Sternberg, DW; Thompson, L	1

Other Studies

2 other study(ies) available for cytarabine and Cardiac Arrest, Sudden

Article	Year
Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Medical and pediatric oncology, 2003, Volume: 41, Issue:1 Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cycle Proteins; Child; Chromosome Breakage; Cisplatin; Cytarabine; Death, Sudden, Cardiac; Etoposide; Fatal Outcome; Humans; Ifosfamide; Infratentorial Neoplasms; Male; Medulloblastoma; Methotrexate; Nuclear Proteins; Polymerase Chain Reaction; Syndrome	2003
Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen. Cancer, 2000, May-01, Volume: 88, Issue:9 Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cerebellar Diseases; Cytarabine; Death, Sudden, Cardiac; Disease-Free Survival; Drug Eruptions; Exanthema; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Treatment Outcome	2000

Article

Year

Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome.

Medical and pediatric oncology, 2003, Volume: 41, Issue:1

Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cycle Proteins; Child; Chromosome Breakage; Cisplatin; Cytarabine; Death, Sudden, Cardiac; Etoposide; Fatal Outcome; Humans; Ifosfamide; Infratentorial Neoplasms; Male; Medulloblastoma; Methotrexate; Nuclear Proteins; Polymerase Chain Reaction; Syndrome

2003

Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.

Cancer, 2000, May-01, Volume: 88, Issue:9

Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cerebellar Diseases; Cytarabine; Death, Sudden, Cardiac; Disease-Free Survival; Drug Eruptions; Exanthema; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Treatment Outcome

2000